RA
Ridhi Agarwal
University of Birmingham, University of Leicester, Keele University
0000-0002-6930-5617
Employment
-
University of Birmingham Medical Statistician2019 - Present
-
University of Birmingham Biostatistician2014 - 2015
Education
-
University of Leicester PhD in Continuous real-time monitoring of extended perinatal mortality in the UK and Crown Dependencies2015 - 2019
-
University of Leicester MSc Medical Statistics2013 - 2014
-
Keele University BSc Mathematics2010 - 2013
Projects & Funding
Projects & funding information is unavailable.
Publications (26)
- Identifying the best diagnostic test for ovarian cancer – synopsis of Refining Ovarian Cancer Test accuracy Scores (ROCkeTS) research Save
- Diagnostic tests for ovarian cancer in premenopausal women with non-specific symptoms (ROCkeTS): prospective, multicentre, cohort study Save
- Methods and mechanisms for measuring and monitoring outcomes from newborn bloodspot screening: a scoping review Save
- A clinical accuracy study protocol for a saliva-based point-of-care lateral flow test to assess protective immunity to tetanus (TETANUS study) Save
- Development of a clinical decision support tool for Primary care Management of lower Urinary tract Symptoms in men: the PriMUS study Save
- Efficacy of oral rinse and other detection methods in detecting oral human papillomavirus infections: The Oromouth cohort study Save
- Investigating harms of testing for ovarian cancer – psychological outcomes and cancer conversion rates in women with symptoms of ovarian cancer: A cohort study embedded in the multicentre ROCkeTS prospective diagnostic study Save
- Risk-prediction models in postmenopausal patients with symptoms of suspected ovarian cancer in the UK (ROCkeTS): a multicentre, prospective diagnostic accuracy study Save
- Study protocol: Optical coherence tomography angiography for the detection of neovascular age-related macular degeneration: A comprehensive multicentre diagnostic accuracy study in the UK-The ATHENA study Save
- Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer Save